Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the pathogen of
coronavirus disease 2019 (COVID‐19), caused the outbreak escalated to pandemic …

Blood-pressure-lowering drugs are proposed to foster SARS-CoV-2 infection by
pharmacological upregulation of angiotensin-converting enzyme 2 (ACE2), the binding …

Coronavirus disease 2019 is a major threat to public health globally. Though its
pathogenesis has not been fully elucidated, angiotensin-converting enzyme 2 (ACE2) has …

Abstract Angiotensin-converting enzyme 2 (ACE2) has been recognized as a potential entry
receptor for SARS-CoV-2 infection. Binding of SARS-CoV-2 to ACE2 allows engagement …

Abstract Angiotensin-converting enzyme 2 (ACE2) is the leading player of the protective
renin–angiotensin system (RAS) pathway but also the entry receptor for severe acute …

Blockers of the renin-angiotensin system (RAS) have been reported to increase the
angiotensin converting enzyme (ACE) 2, the cellular receptor of SARS-CoV-2, and thus the …

The ongoing COVID-19 pandemic has produced serious turmoil world-wide. Lung injury
causing acute respiratory distress syndrome seems to be a most dreaded complication …

This article reviews the correlation between angiotensin‐converting enzyme 2 (ACE2) and
severe risk factors for coronavirus disease 2019 (COVID‐19) and the possible mechanisms …

The rapid spread of a novel coronavirus, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has led to an ongoing pandemic of coronavirus disease 2019 (COVID-19) …

The key link between renin–angiotensin system (RAS) and COVID-19 is ACE2 (angiotensin-
converting enzyme 2), which acts as a double-edged sword, because ACE2 increases the …